Published in J Gen Virol on August 01, 1979
Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line. J Mol Biol (1976) 7.42
Target cell-dependent T cell-mediated lysis of vaccinia virus-infected cells. Eur J Immunol (1975) 3.37
Isolation from turkeys of a cell-associated herpesvirus antigenically related to Marek's disease virus. Am J Vet Res (1970) 2.58
Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J Med Virol (1999) 2.52
Studies on the etiology of Marek's disease. II. Finding of a herpesvirus in cell culture. Proc Soc Exp Biol Med (1968) 2.40
Post-translational alterations in transmembrane topology of the hepatitis B virus large envelope protein. EMBO J (1994) 2.35
Structure of nonintegrated, circular Herpesvirus saimiri and Herpesvirus ateles genomes in tumor cell lines and in vitro-transformed cells. J Virol (1982) 2.23
Size and composition of Marek's disease virus deoxyribonucleic acid. J Virol (1971) 2.10
Intracellular forms of Epstein-Barr virus DNA in human tumour cells in vivo. Nature (1976) 2.10
A new group of oncogenic viruses: reticuloendotheliosis, chick syncytial, duck infectious anemia, and spleen necrosis viruses. J Natl Cancer Inst (1973) 2.03
Precore sequence of hepatitis B virus inducing e antigen and membrane association of the viral core protein. Virology (1986) 2.01
Studies on the etiology of Marek's disease. I. Propagation of the agent in cell culture. Proc Soc Exp Biol Med (1968) 1.97
Circular Epstein-Barr virus genomes of reduced size in a human lymphoid cell line of infectious mononucleosis origin. J Virol (1977) 1.77
Mapping a region of the large envelope protein required for hepatitis B virion maturation. J Virol (1994) 1.73
Human lymphoblastoid cell lines derived from individuals without lymphoproliferative disease contain the same latent forms of Epstein-Barr virus DNA as those found in tumor cells. Int J Cancer (1977) 1.67
Standardized detection of hepatitis B surface antigen: determination of its serum concentration in weight units per volume. Dev Biol Stand (1975) 1.63
Quantitative detection of hepatitis B virus DNA in two international reference plasma preparations. Eurohep Pathobiology Group. J Clin Microbiol (1999) 1.59
Avian reticuloendotheliosis virus: identification of the hematopoietic target cell for transformation. Cell (1981) 1.49
Cell-free transmission and in vivo replication of Marek's disease virus. J Virol (1970) 1.48
Experimental non-A, non-B hepatitis: four types of cytoplasmic alteration in hepatocytes of infected chimpanzees. Virchows Arch B Cell Pathol Incl Mol Pathol (1980) 1.43
Cutoff levels of immunoglobulin M antibody against viral core antigen for differentiation of acute, chronic, and past hepatitis B virus infections. J Clin Microbiol (1986) 1.41
Cardiac myocytes of hearts from patients with end-stage dilated cardiomyopathy do not contain Borrelia burgdorferi DNA. Am Heart J (1999) 1.41
Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey. Proc Natl Acad Sci U S A (1982) 1.39
Nondifferentiation between Lyme disease spirochetes from vector ticks and human cerebrospinal fluid. J Infect Dis (1995) 1.33
Demonstration of a tumor-associated surface antigen in Marek's disease. J Immunol (1975) 1.31
Hepatitis B virus core gene mutations which block nucleocapsid envelopment. J Virol (2000) 1.31
Nucleotide sequence of the ospAB operon of a Borrelia burgdorferi strain expressing OspA but not OspB. Infect Immun (1992) 1.29
Electron microscopy of a herpes virus associated with the agent of Marek's disease in cell culture. Cancer Res (1968) 1.25
Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus. Med Microbiol Immunol (2000) 1.22
Identification of a binding site in the hepatitis B virus RNA pregenome for the viral Pol gene product. Virology (1991) 1.21
Different pattern of elution of poliovirus strains from DEAE-cellulose and aluminium hydroxide gel. Arch Gesamte Virusforsch (1965) 1.21
Epidemiology and clinical manifestations of Lyme borreliosis in childhood. A prospective multicentre study with special regard to neuroborreliosis. Acta Paediatr Suppl (1993) 1.13
Deoxyribonucleic acid of Marek's disease virus in a lymphoblastoid cell line from Marek's disease tumours. J Gen Virol (1974) 1.13
Ultrastructural studies of a herpesvirus of turkeys antigenically related to Marek's disease virus. Virology (1971) 1.12
Assay of hepatitis B virus genome titers in sera of infected subjects. Eur J Clin Microbiol (1986) 1.09
Marek's disease herpesviruses. IV. Molecular characterization of Marek's disease herpesvirus A antigen. J Virol (1983) 1.09
Nucleotide and predicted amino acid sequences of Marek's disease virus homologues of herpes simplex virus major tegument proteins. J Gen Virol (1993) 1.08
Attenuation of Marek's disease virus and study of its properties in two different cell cultures. J Natl Cancer Inst (1970) 1.06
A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV). Avian Dis (1977) 1.06
Liquid-phase hybridization and capture of hepatitis B virus DNA with magnetic beads and fluorescence detection of PCR product. J Virol Methods (1994) 1.05
Etiology of the acrodermatitis chronica atrophicans lesion in Lyme disease. J Infect Dis (1996) 1.05
Suppression of mitogen-induced proliferation of normal spleen cells by macrophages from chickens inoculated with Marek's disease virus. J Immunol (1978) 1.05
Letter: Flower vases and pathogens. Lancet (1974) 1.04
Characterization of unusual escape variants of hepatitis B virus isolated from a hepatitis B surface antigen-negative subject. J Virol (1998) 1.04
Characterization of the endogenous protein kinase activity of the hepatitis B virus. Arch Virol Suppl (1993) 1.03
Extensive homology exists between Marek disease herpesvirus and its vaccine virus, herpesvirus of turkeys. Proc Natl Acad Sci U S A (1984) 1.03
Long-term studies of Marek's disease infection in individual chickens. Avian Dis (1971) 1.02
Marek's disease herpes virus: a cytomegalovirus. Proc Natl Acad Sci U S A (1969) 1.00
Effect of phosphonoacetate on Marek's disease virus replication. J Natl Cancer Inst (1976) 0.98
Extensive mutagenesis of the hepatitis B virus core gene and mapping of mutations that allow capsid formation. J Virol (1999) 0.98
Characterization of Borrelia burgdorferi strains in Lyme arthritis. Scand J Infect Dis (1998) 0.98
HIV-Protease inhibitors reduce cell adherence of Candida albicans strains by inhibition of yeast secreted aspartic proteases. J Invest Dermatol (1999) 0.96
Marek's disease lymphoma of chicken and its causative herpesvirus. Biochim Biophys Acta (1979) 0.96
Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable Virus. J Natl Cancer Inst (1976) 0.96
Identification of an immunoreactive non-proteinaleous component in Borrelia burgdorferi. Med Microbiol Immunol (1991) 0.95
Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products. Virology (1991) 0.95
Selective inhibition by phosphonoacetic acid of MDV DNA replication in a lymphoblastoid cell line. Virology (1976) 0.94
Diagnosis of acute and inapparent hepatitis B virus infections by measurement of IgM antibody to hepatitis B core antigen. J Infect Dis (1980) 0.94
Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol (1989) 0.94
Detection of T-cell surface antigens in a Marek's disease lymphoblastoid cell line. J Natl Cancer Inst (1975) 0.93
Safety and potency aspects in the preparation of an experimental HBsAg vaccine. Dev Biol Stand (1983) 0.93
No homology detectable between Marek's disease virus (MDV) DNA and herpesvirus of the turkey (HVT) DNA. Med Microbiol Immunol (1979) 0.92
Identification and characterization of a Marek's disease virus gene homologous to glycoprotein L of herpes simplex virus. Virology (1994) 0.92
Peripheral facial palsy in childhood--Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand (1990) 0.91
Immunoferritin studies of Marek's disease virus directed intracellular and membrane antigens. Arch Gesamte Virusforsch (1973) 0.91
Deoxyribonucleic acid of Marek's disease virus in virus-induced tumors. J Virol (1973) 0.91
Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls. Int J Cancer (1991) 0.91
Increase in immunoglobulin M antibodies against gut bacteria during acute hepatitis A. Infect Immun (1983) 0.90
Properties of a chicken lymphoblastoid cell line from Marek's disease tumor. J Natl Cancer Inst (1975) 0.90
Morphogenosis of avian infectious bronchitis virus in chicken embryo fibroblasts. J Gen Virol (1968) 0.89
Induction of Marek's disease virus antigens by IdUrd in a chicken lymphoblastoid cell line. J Gen Virol (1977) 0.89
Prolonged haemolytic anaemia in malaria and autoantibodies against triosephosphate isomerase. Lancet (1993) 0.89
Establishment of B-lymphoblastoid cell lines from Marek's disease virus-induced tumors in turkeys. Int J Cancer (1982) 0.89
Recombinant fowlpox viruses expressing the glycoprotein B homolog and the pp38 gene of Marek's disease virus. J Virol (1992) 0.88
Characteristics of murine C-type viruses. II. The behavior of viruses resident in various cell lines and their hybrids on BALB-3T3 and mouse embryo fibroblast cultures. Virology (1974) 0.88
Active immunization against hepatitis B: immunogenicity of a recombinant DNA vaccine in females, heterosexual and homosexual males. Postgrad Med J (1987) 0.88
Structural proteins of Marek's disease virus. Virology (1972) 0.87
Suppression and enhancement of mitogen response in chickens infected with Marek's disease virus and the herpesvirus of turkeys. Infect Immun (1978) 0.86
Interactions between vaccinia virus and sensitized macrophages in vitro. Arch Virol (1975) 0.86
An IgM-producing B lymphoblastoid cell line established from lymphomas induced by a non-defective reticuloendotheliosis virus. J Gen Virol (1982) 0.86
Induction of lymphoid leukosis transplant able tumours and the establishment of lymphoblastoid cell lines. Avian Pathol (1980) 0.86
[Mechanism of the immunological adjuvant effect of vaccinia-virus]. Arch Gesamte Virusforsch (1972) 0.86
Reduction of hepatitis C virus load by H.E.L.P.-LDL apheresis. Eur J Clin Invest (2001) 0.85
Capture and RT-PCR of hepatitis C virus RNA with safety primers. J Virol Methods (1996) 0.85
Studies on the etiology of lymphomas in turkeys: isolation of reticuloendotheliosis in virus. Avian Dis (1977) 0.85
Insertional inactivation of a fowlpox virus homologue of the vaccinia virus F12L gene inhibits the release of enveloped virions. J Gen Virol (1993) 0.85
[Serological subtypes of hepatitis-B antigen (Australia antigen). Local hepatitis-B epidemic of the subtype "Y" with regionally predominating subtype "D"]. Dtsch Med Wochenschr (1972) 0.84
Relationship between Herpesvirus ateles-associated nuclear antigen (HATNA) and the number of virus genome equivalents in HVA-carrying lymphoid lines. J Gen Virol (1981) 0.84
[Increased immunogenicity of plasma membranes of BHK-cells infected by vaccinia virus]. Arch Gesamte Virusforsch (1973) 0.84
Episomal and nonepisomal herpesvirus DNA in lymphoid tumor cell lines. Haematol Blood Transfus (1981) 0.84
Identification and functional analysis of the fowlpox virus homolog of the vaccinia virus p37K major envelope antigen gene. Virology (1992) 0.83
Studies on intracellular and membrane antigens induced by Marek's disease virus. J Gen Virol (1973) 0.83
Mutational analysis of the proteolytic cleavage site of glycoprotein B (gB) of Marek's disease virus. Gene (1994) 0.83
[Inhibition of rubella virus hemagglutination. I. Properties of an inhibitor of rubella virus hemagglutination in vitro present in fetal calf serum]. Arch Gesamte Virusforsch (1968) 0.82
[Cytotoxic reactions in cells infected with Sendai virus]. Arch Gesamte Virusforsch (1972) 0.82
Direct solid-phase radioimmunoassay (dSP-RIA) for detection of antibody to hepatitis B surface (HBs) antigen. Dev Biol Stand (1975) 0.82
[Determination of antibodies against subtypes of hepatitis B surface antigens (HBsAg) (proceedings)]. Zentralbl Bakteriol Orig A (1976) 0.82
Quantitative standardization in the detection of hepatitis B surface antigen: results of a collaborative study involving 74 laboratories. J Biol Stand (1976) 0.82
Assay of preS epitopes and preS1 antibody in hepatitis B virus carriers and immune persons. Med Microbiol Immunol (1990) 0.82